Concerns about quetiapine
Open Access
- 1 June 2015
- journal article
- review article
- Published by Therapeutic Guidelines Limited in Australian Prescriber
- Vol. 38 (3) , 95-97
Abstract
Quetiapine is subsidised by the Pharmaceutical Benefits Scheme to treat schizophrenia andKeywords
This publication has 23 references indexed in Scilit:
- Quetiapine for insomnia: A review of the literatureAmerican Journal of Health-System Pharmacy, 2014
- Recent increase in detection of alprazolam in Victorian heroin‐related deathsMedical Journal of Australia, 2013
- Rethinking psychotropics in nursing homesMedical Journal of Australia, 2013
- Cognitive Effects of Atypical Antipsychotic Medications in Patients With Alzheimer's Disease: Outcomes From CATIE-ADAmerican Journal of Psychiatry, 2011
- The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugsJournal of Anxiety Disorders, 2011
- Impact of FDA Black Box Advisory on Antipsychotic Medication UseArchives of internal medicine (1960), 2010
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Prioritizing Future Research on Off‐Label Prescribing: Results of a Quantitative EvaluationPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Antipsychotic use in the elderly: What doctors say they do, and what they doAustralasian Journal on Ageing, 2008
- Additional Evidence of the Abuse Potential of QuetiapineSouthern Medical Journal, 2007